A case of locally advanced gastric cancer treated with nivolumab, trastuzumab, plus chemotherapy in a neoadjuvant setting

por Jiang, Shi-Yu, Qin, Yan, Shi, Yuan-Kai
Publicado 2019

Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma

por Xu, Jian‐ping, Hao, Xue‐zhi, Zhang, Xiang‐ru, Yang, Sheng, Shi, Yuan‐kai
Publicado 2015

Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases

por Xu, Jian‐ping, Liu, Xiao‐yan, Yang, Sheng, Zhang, Chang‐gong, Wang, Lin, Shi, Yuan‐kai
Publicado 2016

Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase I...

por Hu, Xing-Sheng, Han, Xiao-Hong, Yang, Sheng, Li, Ning, Wang, Lin, Song, Yuan-Yuan, Mu, Hua, Shi, Yuan-Kai
Publicado 2019

Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC T...

por Yang, James Chih-Hsin, Mok, Tony S.K., Lu, Shun, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Shi, Yuan-Kai, Zhang, Li, Soo, Ross A., Morita, Satoshi, Tamura, Tomohide
Publicado 2021

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis

por Zhu, Hao‐Hua, Liu, Yu‐Tao, Feng, Yu, Zhang, Li‐Na, Zhang, Tong‐Mei, Dong, Gui‐Lan, Xing, Pu‐Yuan, Wang, Hong‐Yu, Shi, Yuan‐Kai, Hu, Xing‐Sheng
Publicado 2021

Decreased Prognostic Value of International Prognostic Score in Chinese Advanced Hodgkin Lymphoma Patients Treated in the Contemporary Era

por Wang, Qin, Qin, Yan, Kang, Su-Yi, He, Xiao-Hui, Liu, Peng, Yang, Sheng, Zhou, Sheng-Yu, Zhang, Chang-Gong, Gui, Lin, Yang, Jian-Liang, Sun, Yan, Shi, Yuan-Kai
Publicado 2016

Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

por Liu, Yu-Tao, Hao, Xue-Zhi, Li, Jun-Ling, Hu, Xing-Sheng, Wang, Yan, Wang, Zi-Ping, Wang, Hong-Yu, Wang, Bin, Han, Xiao-Hong, Zhang, Xiang-Ru, Shi, Yuan-Kai
Publicado 2015

A retrospective analysis of real-world outcomes of elderly Chinese patients with diffuse large B-cell lymphoma

por Liu, Peng, Han, Ying, Jiang, Shi-Yu, He, Xiao-Hui, Qin, Yan, Gui, Lin, Zhou, Sheng-Yu, Zhou, Li-Qiang, Yang, Jian- Liang, Yang, Sheng, Wen, Ting-Yu, Shi, Yuan-Kai
Publicado 2019

GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphom...

por Wang, Jing-jing, Dong, Mei, He, Xiao-hui, Li, Ye-xiong, Wang, Wei-hu, Liu, Peng, Yang, Jian-liang, Gui, Lin, Zhang, Chang-gong, Yang, Sheng, Zhou, Sheng-yu, Shi, Yuan-kai
Publicado 2016

Efficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma: a retrospective study of 64 patients from a single center

por He, Xiao-Hui, Li, Bo, Zou, Shuang-Mei, Dong, Mei, Zhou, Sheng-Yu, Yang, Jian-Liang, Xue, Li-Yan, Yang, Sheng, Liu, Peng, Qin, Yan, Zhang, Chang-Gong, Han, Xiao-Hong, Shi, Yuan-Kai
Publicado 2012

Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Lymphomas

por Zhou, Ping, Liu, Peng, Zhou, Sheng-Yu, He, Xiao-Hui, Han, Xiao-Hong, Qin, Yan, Yang, Sheng, Zhang, Chang-Gong, Gui, Lin, Yao, Jia-Rui, Zhao, Li-Ya, Zhang, Shu-Xiang, Sun, Yan, Shi, Yuan-Kai
Publicado 2015

Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI

por Liu, Yu-Tao, Zhang, Kai, Li, Cheng-Cheng, Hu, Xing-Sheng, Jiang, Jun, Hao, Xue-Zhi, Wang, Yan, Li, Jun-Ling, Xing, Pu-Yuan, Yang, Sheng, Zhang, Xin, Wang, Guo-Qiang, Cai, Shang-Li, Shi, Yuan-Kai
Publicado 2019

R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma

por He, Xiao-Hui, Li, Bo, Yang, Sheng, Lu, Ning, Zhang, Xun, Zou, Shuang-Mei, Li, Ye-Xiong, Song, Yong-Wen, Zheng, Shan, Dong, Mei, Zhou, Sheng-Yu, Yang, Jian-Liang, Liu, Peng, Zhang, Chang-Gong, Qin, Yan, Feng, Feng-Yi, Shi, Yuan-Kai
Publicado 2012

Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial

por Liu, Yu-Tao, Hao, Xue-Zhi, Liu, De-Ruo, Cheng, Gang, Zhang, Shu-Cai, Xiao, Wen-Hua, Hu, Yi, Liu, Jun-Feng, He, Ming, Ding, Cui-Min, Zhang, Li, Wang, Jun, Li, Hui, Dong, Gui-Lan, Zhi, Xiu-Yi, Li, Jian, Shi, Yuan-Kai
Publicado 2020

Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients

por Huang, Li‐Ling, Hu, Xing‐Sheng, Wang, Yan, Li, Jun‐Ling, Wang, Hong‐Yu, Liu, Peng, Xu, Jian‐Ping, He, Xiao‐Hui, Hao, Xue‐Zhi, Jiang, Pei‐Di, Liu, Yu‐Tao, Luo, Jian, Zhou, Sheng‐Yu, Wang, Jin‐Wan, Yang, Jian‐Liang, Qin, Yan, Yuan, Peng, Lin, Lin, Shi, Yuan‐Kai
Publicado 2021

Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study

por Shi, Yuan-Kai, Hong, Xiao-Nan, Yang, Jian-Liang, Xu, Wei, Huang, Hui-Qiang, Xiao, Xiu-Bin, Zhu, Jun, Zhou, Dao-Bin, Han, Xiao-Hong, Wu, Jian-Qiu, Zhang, Ming-Zhi, Jin, Jie, Ke, Xiao-Yan, Li, Wei, Wu, De-Pei, Yang, Shen-Miao, Du, Xin, Jia, Yong-Qian, Liu, Ai-Chun, Liu, Dai-Hong, Shen, Zhi-Xiang, Zhang, Lian-Sheng, James, Leonard, Hellriegel, Edward
Publicado 2021

Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study

por Zhou, Qing, Zhang, He-Long, Jiang, Li-Yan, Shi, Yuan-Kai, Chen, Yuan, Yu, Jin-Ming, Zhou, Cai-Cun, He, Yong, Hu, Yan-Ping, Liang, Zong-An, Pan, Yue-Yin, Zhuo, Wen-Lei, Song, Yong, Wu, Gang, Chen, Gong-Yan, Lu, You, Zhang, Cui-Ying, Zhang, Yi-Ping, Cheng, Ying, Lu, Shun, Wang, Chang-Li, Zhou, Jian-Ying, Liu, Yun-Peng, He, Jian-Xing, Wang, Jie, Wu, Yi-Long
Publicado 2023